...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Wow…

...am surprised to see any life still remains here or on the rvx board. Anywho hope everyone is well besides the obvious. Any prognosis for Zen? Still holding free shares but haven't paid attention for years so thought I should check in. 

Share
New Message
Please login to post a reply